3.5.1 Lower NII-RF Associated With Worse Mental Health and Increased Disability
Among all participants (including patients and HCs), significantly positive associations were observed between NII-RF and MCS or BDS across major white matter tracts (Figures 5 and 6, Table 3). Note that the regions where NII-RF significantly associated with MCS and BDS largely overlapped with the regions where ME/CFS participants exhibited significantly lower NII-RF compared to HCs.
That section of the paper reinforces that low NII-Restricted Fraction was associated with worse health. BDS is Bells Disability Scale - lower numbers mean lower function. So, a 'positive association' means higher NII-RF was associated with better function.
******
Diffusion Basis Restricted Fraction as a Putative Magnetic Resonance Imaging Marker of Neuroinflammation: Histological Evidence, Diagnostic Accuracy, and Translational Potential
That 2025 paper discusses the Restricted Fraction measure.
Here's the abstract:
Diffusion basis spectrum imaging–derived restricted fraction (DBSI-RF) isolates the low apparent diffusion coefficient water signal attributed to cellular crowding. It is therefore proposed as a putative magnetic resonance imaging (MRI) marker of neuroinflammation.
The purpose of this narrative review is to evaluate animal and human studies that compared DBSI-RF with histopathological benchmarks and clinical parameters. Across inflammatory demyelination, viral encephalitis, traumatic brain injury, and neurodegenerative disorders, DBSI-RF correlated moderately to strongly with immune cell density and distinguished inflammation from demyelinating or axonal pathology. In acute multiple sclerosis, com-bined isotropic fractions predicted lesion evolution, clinical subtypes, and deep-learning models that included DBSI-RF classified lesion subtypes with high accuracy. DBSI-RFmight also be used to track putative neuroinflammation associated with psychosocial stress, mood disorders, and anxiety disorders.
The strengths of the method include sensitivity to subclinical changes and the concurrent mapping of coexisting edema, demyelination, and axon loss. Limitations include non-specific etiology features, a demanding acquisition protocol, and limited large-scale human validation. Overall, DBSI-RF may demonstrate a promising diagnostic and prognostic accuracy, warranting standardized, multicenter, prospective trials and external validation.
Overall, DBSI-RF is hypothesized to serve as an MRI marker of neuroinflammation, since cellular infiltration and glial activation in neural tissue increase the density of cells. Thus, the fraction of the restricted diffusion compartment is also elevated [16–21].
In optic neuritis, the DBSI restricted fraction increases with the number of DAPI-counted nuclei and decreases with anti-inflammatory treatment.
It's clear from that abstract and quotes that RF is seen as correlating with immune cell density and a possible measure of neuroinflammation - more RF indicates more neuroinflammation. But, this Shan study found low RF in ME/CFS..... I don't know if the Shan et al study are reporting things differently?
The abstract of the 2025 paper also calls this measure 'promising' and warranting trials and validation in humans. Clearly, Shan and the team are using cutting edge technology, which is great, but it means it's a bit hard to know what it means.
Last edited: